Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21

Item

http://www.wikidata.org/entity/Q36970160

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21

@en

type

Item

label

Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21

@en

prefLabel

Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21

@en

P1476

Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21

@en

P2093

Ae Lee Jeong

http://www.w3.org/2001/XMLSchema#string

Ariundavaa Boldbaatar

http://www.w3.org/2001/XMLSchema#string

Hye In Ka

http://www.w3.org/2001/XMLSchema#string

Hyo Jeong Yong

http://www.w3.org/2001/XMLSchema#string

Jeong Su Park

http://www.w3.org/2001/XMLSchema#string

Jong Dai Kim

http://www.w3.org/2001/XMLSchema#string

Sora Han

http://www.w3.org/2001/XMLSchema#string

Sunyi Lee

http://www.w3.org/2001/XMLSchema#string

Won-Young Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulators

Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions

Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome.

Standards of medical care in diabetes--2010.

Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjects

Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?

Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue.

Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.

Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes.

P304

5479627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/5479627

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Eun-Jung Rhee

Y Yang

P577

2016-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27313611

http://www.w3.org/2001/XMLSchema#string

P932

4893584

http://www.w3.org/2001/XMLSchema#string